Voluntary Recall Information

Philips Respironics Sleep and Respiratory Care devices


In June 2021, after discovering a potential health risk related to the foam in certain CPAP, BiPAP and Mechanical Ventilator devices, Philips Respironics issued a voluntary Field Safety Notice (outside U.S.) / voluntary recall notification (U.S. only).

News and updates    

US icon

Approximately 2,840,000 new devices and repair kits produced to meet the U.S. registration demand*

Approximately 2,490,000 devices remediated and in the hands of U.S. patients and Durable Medical Equipment providers (DMEs)**

Are you or your patient waiting for a replacement device? We may be trying to reach you for more information or to take additional action.

Philips response to recent media articles related to Philips Respironics’ voluntary recall notification/field safety notice

July 2023 latest results and conclusions for sleep therapy devices related to the impact of ozone cleaning shows no appreciable harm to health in patients


Philips Respironics completed the analyses for System One and DreamStation Go sleep therapy devices indicating that the volatile organic compounds (VOCs) and the particulate matter (PM) emissions related to foam degradation are within the appliable safety limits. Additional visual assessments have been performed and confirm the low prevalence of significant foam degradation.

* As of August 31, 2023

** A remediated device includes new, recertified, alternative devices sent as replacements for affected units, devices shipped to DMEs who are directly handling patient remediations, and financial payment. Repair kits are utilized in the rework process to create a recertified unit. To learn more, click here.

You are about to visit a Philips global content page


You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.